Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Work In Process (2021 - 2025)

Organogenesis Holdings (ORGO) has 5 years of Work In Process data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Work In Process rose 37.05% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 37.05%, while the annual FY2025 figure was $1.3 million, 37.05% up from the prior year.
  • Work In Process reached $1.3 million in Q4 2025 per ORGO's latest filing, up from $1.1 million in the prior quarter.
  • Across five years, Work In Process topped out at $1.7 million in Q2 2023 and bottomed at $810000.0 in Q4 2023.
  • Average Work In Process over 5 years is $1.1 million, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Work In Process: skyrocketed 64.94% in 2023, then tumbled 50.67% in 2024.
  • A 5-year view of Work In Process shows it stood at $991000.0 in 2021, then increased by 3.13% to $1.0 million in 2022, then fell by 20.74% to $810000.0 in 2023, then rose by 13.95% to $923000.0 in 2024, then soared by 37.05% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $1.3 million in Q4 2025, $1.1 million in Q3 2025, and $825000.0 in Q2 2025.